Wall Street Analysts See a 31.02% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?

LifeStance Health has a consensus price target implying 31% upside, and the article notes an improving trend in earnings estimate revisions. While it cautions that price targets are often unreliable, the direction of revisions suggests near-term upside potential for the stock. The piece is a modestly positive analyst-focused update rather than a new operating or financial disclosure.

Analysis

LifeStance Health has a consensus price target implying 31% upside, and the article notes an improving trend in earnings estimate revisions. While it cautions that price targets are often unreliable, the direction of revisions suggests near-term upside potential for the stock. The piece is a modestly positive analyst-focused update rather than a new operating or financial disclosure.